Skip to Content
COVID-19 Response and Update
Amneal
  • Corporate
  • India
  • About
        • AboutWe expand access to high-quality medicines
        • Our Purpose & Commitments
        • Rise Lead Succeed Culture
        • India Leadership
        • Site Locations
        • Awards & Recognition
  • Responsibility
  • Products
        • ProductsInnovative medicines and delivery technologies for patients
        • OUR PORTFOLIO
          • Oncology
          • Neurology
          • Hospital
          • Ophthalmology
        • Quality
        • Drug Safety
          • Adverse Event Reporting
          • Product Complaints
  • Careers
        • CareersHelp making medicine accessible for all
        • Total Rewards
        • Search Our Career Opportunities
  • Contact
Advancing CNS care

Neurology

Our Neurology and Central Nervous System (CNS) portfolio is designed to address some of India’s most critical and complex neurological conditions. We are elevating the standard of care for conditions like Multiple Sclerosis, Migraine and soon Alzheimer’s. And we are leaning into our U.S. market leadership in Parkinson’s Disease to bring innovative future therapies for Indian patients and their caregivers.

Our NeuHope commercial team, leads this mission with robust experience and a clear vision: to bring new hope to healthcare providers and their patients one innovation at a time.

Product Catalogue
Product Catalogue
  • Privacy Notice
  • Copyright & Legal Disclaimer
  • Web Accessibility
  • NABP DDA Accreditation
  • Linkedin
  • X
  • Facebook
  • Youtube
© 2026 Amneal Pharmaceuticals LLC.
All rights reserved.